Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer (NCT06530615) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer
United States119 participantsStarted 2024-02-05
Plain-language summary
This project will study and characterize Microplastic (MP) burden in the lungs of patients undergoing Bronchoalveolar Levage (BAL) in thoracic clinics at Moffitt.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* English or Spanish-speaking patients scheduled for bronchoscopy/bronchoalveolar lavage (BAL) in thoracic clinics at Moffitt.
Exclusion Criteria:
* Patients with a known prior history of lung cancer or that have undergone a Bronchoalveolar Lavage (BAL) procedure at any time in the past in the involved lung targeted for BAL.
* Patients that have had any prior lung or thoracic or surgeries or procedures (examples: removal of lung or portions of the involved lung (lobectomy, pneumonectomy, wedge resection/segmentectomy).
* Patients with specimens that are considered to be non-adequate as true Bronchoalveolar Lavage Fluid (BALF) (i.e., absence of alveolar macrophages) after pathologist's evaluation will be excluded from the study.
What they're measuring
1
Characterization of Microplastic (MP) Burden in the Lungs
Timeframe: Up to 24 Months
Trial details
NCT IDNCT06530615
SponsorH. Lee Moffitt Cancer Center and Research Institute